Assessment of Tear Film Anomalies in Childhood Obesity

Abstract

Purpose To determine if childhood obesity has an effect on the ocular surface and tear film of children who are afflicted.

Methods Patients who had childhood obesity, 85 eyes, and patients who were healthy, 75 eyes, were enrolled in this prospective and comparative study. The tear film breakup time (TF-BUT), tear meniscus area and height (TMA and TMH) values, Schirmer test scores, and ocular surface disease index (OSDI) scores were obtained for all participants.

Results The TMH, TMA, TF-BUT, and Schirmer test results were statistically significantly lower in the obesity group (p < 0.001 for all). The children with obesity and insulin resistance had lower TMH, TMA, TF-BUT, and Schirmer test results when compared to the children without insulin resistance (p < 0.05 for all). The body mass index was found to be correlated with the TMH, TMA, TF-BUT, and Schirmer test results (p < 0.001 for all).

Conclusion Children with obesity had lower TMA, TMH, TF-BUT, and Schirmer test results than healthy subjects. When insulin resistance was added to obesity, these values were even lower.

Zusammenfassung

Zweck Untersuchungen zum Zusammenhang zwischen Fettleibigkeit bei Kindern und dem Tränenfilm betroffener Kinder.

Methoden Von Patienten mit Adipositas im Kindesalter wurden 85 Augen und von gesunden Patienten 75 Augen in diese prospektive und vergleichende Designstudie eingeschlossen. Für alle Teilnehmer wurden die Werte für die Tränenfilmauflösungszeit (TF-BUT), die Tränenmeniskusfläche und -höhe (TMA und TMH), die Schirmer-Testwerte und die OSDI-Werte (OSDI: Ocular Surface Disease Index) ermittelt.

Ergebnisse Die TMH-, TMA-, TF-BUT- und Schirmer-Testergebnisse waren in der Adipositasgruppe statistisch signifikant niedriger (p < 0,001 für alle). Die Kinder mit Fettleibigkeit und Insulinresistenz hatten niedrigere TMH-, TMA-, TF-BUT- und Schirmer-Testergebnisse im Vergleich zu den Kindern ohne Insulinresistenz (p < 0,05 für alle). Es wurde festgestellt, dass der Body-Mass-Index mit den TMH-, TMA-, TF-BUT- und Schirmer-Testergebnissen korreliert (p < 0,001 für alle).

Schlussfolgerung Die Kinder mit Adipositas hatten niedrigere TMA-, TMH-, TF-BUT- und Schirmer-Testergebnisse als gesunde Probanden. Wenn die Insulinresistenz zu Fettleibigkeit hinzugefügt wurde, waren diese Werte noch niedriger.

Key words

cornea - pediatric ophthalmology - conjunctiva

Schlüsselwörter

Kornea - Kinderophthalmologie - Bindehaut

• References

• 1 Chia EM, Mitchell P, Rochtchina E. et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2003; 31: 229-232
• 2 Dana R, Bradley JL, Guerin A. et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States health care system. Am J Ophthalmol 2019; 202: 47-54
• 3 Alves M, Dias AC, Rocha EM. Dry eye in childhood: epidemiological and clinical aspects. Ocul Surf 2008; 6: 44-51
• 4 Rojas-Carabali W, Uribe-Reina P, Muñoz-Ortiz J. et al. High prevalence of abnormal ocular surface tests in a healthy pediatric population. Clin Ophthalmol 2020; 14: 3427-3438
• 5 Lemp MA, Baudouin C, Baum J. et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf 2007; 5: 75-92
• 6 Hessen M, Akpek EK. Dry eye: an inflammatory ocular disease. J Ophthalmic Vis Res 2014; 9: 240-250
• 7 Wan KH, Chen LJ, Young AL. Efficacy and Safety of Topical 0.05 % Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis. Ocul Surf 2015; 13: 213-225
• 8 Han JC, Lawlor DA, Kimm SYS. Childhood obesity. Lancet 2010; 375: 1737-1748
• 9 Sahoo K, Sahoo B, Choudhury AK. et al. Childhood obesity: causes and consequences. J Family Med Prim Care 2015; 4: 187-192
• 10 Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol 2007; 52: 180-195
• 11 Wolffsohn JS, Arita R, Chalmers R. et al. TFOS DEWS II diagnostic methodology report. Ocul Surf 2017; 15: 539-574
• 12 Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol 2008; 1: 53-60
• 13 Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol 2007; 52: 180-195
• 14 Craig JP, Nichols KK, Akpek EK. et al. TFOS DEWS II definition and classification report. Ocul Surf 2017; 15: 276-283
• 15 Pflugfelder SC. Anti-inflammatory therapy of dry eye. Am J Ophthalmol 2004; 137: 337-342
• 16 Lam H, Bleiden L, de Paiva CS. et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009; 147: 198-205
• 17 Chang RC, Shi L, Huang CC. et al. High-fat diet-induced retinal dysfunction. Invest Ophthalmol Vis Sci 2015; 56: 2367-2380
• 18 Singh R, Joseph A, Umapathy T. et al. Impression cytology of the ocular surface. Br J Ophthalmol 2005; 89: 1655-1659
• 19 Cheung N, Wong TY. Obesity and eye disease. Surv Ophthalmol 2007; 52: 180-195
• 20 Gürdal C, Saraç O, Genç I. et al. Ocular surface and dry eye in Gravesʼ disease. Curr Eye Res 2011; 36: 8-13
• 21 Resch MD, Marsovszky L, Németh J. et al. Dry eye and corneal langerhans cells in systemic lupus erythematous. J Ophthalmol 2015; 2015: 543835
• 22 Uzel MM, Citirik M, Kekilli M. et al. Local ocular surface parameters in patients with systemic celiac disease. Eye (Lond) 2017; 31: 1093-1098
• 23 Valle M, Martos R, Gascón F. et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005; 31: 55-62
• 24 Marseglia L, Manti S, DʼAngelo G. et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2014; 16: 378-400
• 25 Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2012; 15: 487-492
• 26 Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001; 108: 586-592
• 27 Tseng SC, Hirst LW, Maumenee AE. et al. Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology 1984; 91: 545-552
• 28 Nichols KK, Foulks GN, Bron AJ. et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52: 1922-1929
• 29 Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology 2017; 124 (11S): S20-S26
• 30 Inoue K, Kato S, Ohara C. et al. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea 2001; 20: 798-801
• 31 Inoue K, Okugawa K, Amano S. et al. Blinking and superficial punctate keratopathy in patients with diabetes mellitus. Eye (Lond) 2015; 19: 418-421
• 32 Marfurt CF, Echtenkamp SF. The effect of diabetes on neuropeptide content in the rat cornea and iris. Invest Ophthalmol Vis Sci 1995; 36: 1100-1106
• 33 Gupta PK, Venkateswaran N, Heinke J. et al. Association of meibomian gland architecture and body mass index in a pediatric population. Ocul Surf 2020; 18: 657-662
• 34 Baser G, Yıldız N, Calan M. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res 2017; 42: 661-665
• 35 Hotamisligil GS, Arner P, Caro JF. et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415
• 36 Burhans MS, Hagman DK, Kuzma JN. et al. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol 2018; 9: 1-58
• 37 Chen L, Chen R, Wang H. et al. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol 2015; 2015: 508409
• 38 Esser N, Legrand-Poels S, Piette J. et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-150